COVID-19 in patients with neurological disorders
Brain Behav Immun Health
.
2020 Oct:8:100131.
doi: 10.1016/j.bbih.2020.100131.
Epub 2020 Aug 25.
Authors
Sanjeeva Reddy Onteddu
1
,
Krishna Nalleballe
1
,
Suman Siddamreddy
2
,
Madhu Jasti
3
,
Sukanthi Kovvuru
1
,
Vasuki Dandu
4
,
Bhaskar Roy
5
Affiliations
1
Department of Neurology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
2
Department of Medicine, University of Arkansas for Medical Sciences Baptist Health Program, North Little Rock, AR, USA.
3
Department of Neurology, University of Maryland Baltimore Washington Medical Center, Glen Burnie, MD, USA.
4
Department of Medicine, University of Arkansas for Medical Sciences /Baptist Health Program, North Little Rock, AR, USA.
5
Department of Neurology, Yale University School of Medicine, New Haven, CT, USA.
PMID:
32864634
PMCID:
PMC7445184
DOI:
10.1016/j.bbih.2020.100131
No abstract available
Keywords:
COVID-19; Clinical outcomes; Neurological disorders.
Grants and funding
UL1 TR001863/TR/NCATS NIH HHS/United States